Fisher & Paykel HealthcareFSPKF +9.59%90 OCF Yield % is 2.94 as of Jun. 26, 2026, which is 15% above its 10-year median of 2.55. GuruFocus rates FSPKF with a GF Score™ of 90/100 and a GF Value™ of $27.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Fisher & Paykel Healthcare ranks better than 55.4% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Fisher & Paykel Healthcare OCF Yield % Related Terms
Fisher & Paykel Healthcare OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (FSPKF) has a OCF Yield % of 2.94 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Fisher & Paykel Healthcare and its competitors. This is 15% above median its historical median of 2.55. Over the past decade, Fisher & Paykel Healthcare's OCF Yield % has ranged from 1.47 to 4.42. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #380 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 44.6%.
Is Fisher & Paykel Healthcare's OCF Yield % too high?
Fisher & Paykel Healthcare's current OCF Yield % of 2.94 is 15% above median its 10-year median of 2.55. Over the past 10 years, this metric has ranged from a low of 1.47 to a high of 4.42. The Medical Devices & Instruments industry median OCF Yield % is 1.79. Fisher & Paykel Healthcare's value of 2.94 is 64.7% above this industry median. Based on the distribution chart, Fisher & Paykel Healthcare ranks #380 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fisher & Paykel Healthcare has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #380 out of 852 companies for OCF Yield %. This puts Fisher & Paykel Healthcare in the upper half of its industry. The industry median OCF Yield % is 1.79. Fisher & Paykel Healthcare's value of 2.94 is 64.7% above this benchmark. Historically, Fisher & Paykel Healthcare's own OCF Yield % has ranged from 1.47 to 4.42 over the past decade. While the company's 10-year median is 2.55 vs. the industry median of 1.79, Fisher & Paykel Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fisher & Paykel Healthcare's current OCF Yield % of 2.94 is 64.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Fisher & Paykel Healthcare and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fisher & Paykel Healthcare's current OCF Yield % is 2.94, which is 15% above median its own 10-year median of 2.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (FSPKF) is currently considered Modestly Undervalued. The stock's GF Value™ is $27.38, compared to a current price of $22.52 — trading 17.8% below its estimated fair value. The current OCF Yield % is 2.94, which is 15% above median its 10-year median of 2.55 and 64.7% above the Medical Devices & Instruments industry median of 1.79. Fisher & Paykel Healthcare's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FSPKF), the current OCF Yield % is 2.94 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (FSPKF) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of $22.52 is trading 17.8% below its estimated GF Value™ of $27.38.
GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.
Key valuation signals for FSPKF:
OCF Yield %: 2.94 (15% above median its 10-year median of 2.55)
GF Value™: $27.38 vs. price of $22.52 (17.8% below fair value)
Industry Position: 64.7% above the Medical Devices & Instruments median (#380 of 852)
No single metric tells the full story. See the FSPKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
90GF Score
Get the complete analysis for FSPKF
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSPKF has been successfully added to your 
